Vaccine for Porcine
Reproductive and Respiratory Syndrome (PRRS) Market
Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Size and Growth
The Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market is experiencing significant growth due to increasing awareness of disease impact and vaccination benefits. The market size is projected to reach approximately $900 million by 2028, driven by advancements in vaccine technology and rising pork production demands globally.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ CNADC
◍ Qilu Animal Health
◍ Sinopharm
◍ Boehringer-Ingelheim
The PRRS vaccine market features key players like Boehringer Ingelheim and Zoetis, focusing on innovative vaccines and research. Companies enhance market growth through R&D and strategic partnerships. For example, Zoetis reported revenues of $6.7 billion in 2022, while Boehringer Ingelheim's animal health segment earned approximately $5 billion.
◍ Tianjin Ruipu Biological Technology Co., Ltd.
◍ MSD Animal Health
◍ CAVAC
◍ Chengdu Tianbang Biological Products Co., Ltd.
◍ Ceva
◍ Guangdong Wens Dahuanong Biotechnology Co., Ltd.
◍ Phibro Animal Health
◍ Guangdong Yongshun Biological Pharmaceutical Co Ltd
◍ Komipharm
◍ Tiankang
◍ Jinyu Bio-Technology
◍ Agrovet
◍ Plec Bioengineering Co., Ltd.
◍ Zoetis
Request Sample Report
Market Segmentation
By Application
Government Tender
Marketing
Request Sample Report
By Product
Live Vaccine
Inactivated Vaccine
Market Growth
Request Sample Report
$ X Billion USD
